Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-06-19

FDA Approved: BIMATOPROST — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved the original application for BIMATOPROST from Somerset Therapeutics, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimatoprost (bimatoprost)

Snippet

ORIG AP for BIMATOPROST (BIMATOPROST)